Search the Newsreel

HASI (NYSE: HASI) boosts 2028 EPS guidance after strong Q2 2026

SUSS MicroTec SE bestätigt Ergebnisprognose für das Geschäftsjahr 2026

Tarsus Pharmaceuticals to report Q2 2026 financial results on August 6

Tarsus Pharmaceuticals will host a live webcast on August 6, 2026, to discuss its second-quarter financial results and provide a corporate update. The webcast, scheduled for 5:00 a.m. PT / 8:00 a.m. ET, will offer insights into the company's progress, including its FDA-approved XDEMVY® …

Tarsus Pharmaceuticals to Host Second Quarter 2026 Financial Results Webcast and Corporate Update

Tarsus Pharmaceuticals, Inc. announced it will host a live webcast on August 6, 2026, at 5:00 a.m. PT to discuss its second-quarter 2026 financial results and provide a corporate update. The company focuses on innovative treatments in eye care, dermatology, and infectious diseases, with …

Sensus Healthcare Inc (SRTS) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Sensus Healthcare Inc (SRTS), including its current earnings forecast score of 8.00 and an average price target of $8.00 based on 4 analysts. It details expected revenue for the next quarter at $4.60 million and an anticipated …

Prosus-aandeel test steun op €40,99: Technische vooruitzichten

Rathbones Group PLC Sells 77,222 Shares of HA Sustainable Infrastructure Capital, Inc. $HASI

Rathbones Group PLC reduced its stake in HA Sustainable Infrastructure Capital, Inc. (HASI) by 16.4%, selling 77,222 shares but still retaining 394,662 shares valued at approximately $14.5 million. Despite this sale, institutional investors collectively own 96.14% of the company, and analysts maintain a "Moderate …

Lazard Asset Management LLC Raises Stock Holdings in Consensus Cloud Solutions, Inc. $CCSI

Lazard Asset Management LLC significantly increased its stake in Consensus Cloud Solutions, Inc. (NASDAQ:CCSI) by 223.4% in the first quarter, bringing its total holdings to 69,299 shares valued at $1.65 million. This comes as Consensus Cloud Solutions exceeded quarterly earnings and revenue expectations, reporting …

Trading Systems Reacting to (HASI) Volatility

AI models from Stock Traders Daily indicate a neutral near and mid-term outlook for Hannon Armstrong Sustainable Infrastructure Capital Inc. (HASI), but maintain a long-term positive bias. The analysis highlights key support and resistance levels, with an exceptional 24.9:1 risk-reward setup targeting a 7.1% …

Healthcare of Ontario Pension Plan Trust Fund Has $1.65 Million Holdings in HA Sustainable Infrastructure Capital, Inc. $HASI

The Healthcare of Ontario Pension Plan Trust Fund significantly reduced its stake in HA Sustainable Infrastructure Capital, Inc. (HASI) by 50% in the first quarter, now holding 45,015 shares valued at $1.65 million. Despite this reduction, institutional investors collectively own 96.14% of the stock. …

Amundi Lowers Stake in HA Sustainable Infrastructure Capital, Inc. $HASI

Amundi reduced its stake in HA Sustainable Infrastructure Capital, Inc. (HASI) by 2% in the first quarter, selling 48,816 shares but retaining 2.42 million shares valued at approximately $89 million. Despite this, institutional investors collectively own 96.14% of the company. HA Sustainable Infrastructure Capital …

Sustained Infrastructure Holding Company Reports Earnings Results for the Second Quarter Ended June 30, 2026

The Bull Case For Tarsus Pharmaceuticals (TARS) Could Change Following Sharp EPS Estimate Cuts Amid Rising Sales

Tarsus Pharmaceuticals (TARS) is facing significantly lowered consensus earnings-per-share (EPS) estimates and a low analyst ranking ahead of its June 2026 quarterly results, despite projected year-over-year revenue increases. This tension between growing sales and weakening profit expectations raises questions about the company's long-term investment …

Toyota Tsusho (TSE:8015) Stock Faces Margin Squeeze Despite Strong EPS Growth

Groupe la Francaise Has $6.74 Million Stock Holdings in HA Sustainable Infrastructure Capital, Inc. $HASI

Groupe la Francaise decreased its stake in HA Sustainable Infrastructure Capital, Inc. (HASI) by 16.4% in Q1, selling 36,000 shares but retaining 183,651 shares valued at $6.74 million. HASI outperformed Q1 expectations with EPS of $0.77 and revenue of $124.23 million, while institutional investors …

37,492 Shares in Consensus Cloud Solutions, Inc. $CCSI Bought by Principal Financial Group Inc.

Principal Financial Group Inc. acquired 37,492 shares of Consensus Cloud Solutions (NASDAQ:CCSI), totaling approximately $890,000, which gives them a 0.20% stake in the company. Institutional investors hold a significant 93.93% of Consensus Cloud Solutions. The company recently surpassed quarterly earnings and revenue expectations, reporting …

Sensus Healthcare Inc (SRTS) Financial Health: Profitability & Balance Sheet Analysis

Sensus Healthcare Inc (SRTS) has a current financial score of 6.52, ranking 148th in the Healthcare Equipment & Supplies industry, indicating robust financial status but low operating efficiency. Its latest quarterly revenue decreased by 59.32% year-over-year to $3.39M, and net profit saw a 2.10% …

Acusensus Ltd Revenue Breakdown – ASX:ACE

CCSI|Consensus Cloud Solutions Inc|Price:36.400|Chg%:+0.670

This article provides a comprehensive stock analysis of Consensus Cloud Solutions Inc (CCSI) by TradingKey, highlighting its healthy fundamentals, high growth potential, and fair valuation within the Software & IT Services industry. The company's stock is rated as a "Strong Buy" by multiple analysts, …

TARS Maintained by Mizuho -- Price Target Lowered to $98.00

Mizuho has maintained an "Outperform" rating for Tarsus Pharmaceuticals (TARS) but lowered its price target to $98.00 from $100.00. While GuruFocus's GF Value suggests the stock is significantly undervalued, the company exhibits low profitability and negative insider activity, prompting caution for investors despite analyst …

Mizuho Trims Price Target on Tarsus Pharmaceuticals to $98 From $100, Keeps Outperform Rating

Mizuho has adjusted its price target for Tarsus Pharmaceuticals (TARS) from $100 to $98, while maintaining an Outperform rating on the stock. This revision comes after the company's recent earnings report. The firm highlighted that the Q2 report showed a notable increase in Xdemvy …

Consensus Cloud Solutions Inc (CCSI) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis of Consensus Cloud Solutions Inc (CCSI), noting its current valuation score of 9.15 and P/E ratio of 7.72. The company ranks 103 out of 486 in the Software & IT Services industry based on this score. The analysis …

First Trust Advisors LP Acquires 77,617 Shares of HA Sustainable Infrastructure Capital, Inc. $HASI

First Trust Advisors LP significantly increased its stake in HA Sustainable Infrastructure Capital, Inc. (HASI) by 25.4% in the first quarter, now owning 382,976 shares valued at $14.1 million. The real estate investment trust reported strong first-quarter earnings of $0.77 per share and revenues …

Consensus Cloud Solutions Inc (CCSI) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Consensus Cloud Solutions Inc (CCSI), detailing its price momentum score, support and resistance levels, and various technical indicators. It also includes information on moving averages and addresses frequently asked questions regarding technical ratings and buy/sell signals for …

HA Sustainable Infrastructure Capital (HASI) Secures New Credit Facilities, Is The Valuation Too Rich?

SPEG|Silver Pegasus Acquisition Corp|Price:10.330|

Sensus Healthcare Q2 update will stream live Aug. 13 at 4:30 p.m.

Sensus Healthcare, Inc. (Nasdaq: SRTS) will report its second quarter 2026 financial results on Thursday, August 13, 2026. The company will host a conference call and webcast at 4:30 PM Eastern time to discuss the results, provide a business update, and answer questions. Participants …

Sensus Healthcare to Report Second Quarter 2026 Financial Results and Hold Business Update Conference Call on August 13, 2026

Sensus Healthcare, Inc. will announce its second-quarter 2026 financial results on Thursday, August 13, 2026. Following the release, management will host a conference call at 4:30 PM Eastern time to discuss the results, provide a business update, and answer questions. The company focuses on …

Sensus Healthcare updates financial calendar with quarterly results conference call scheduled

Sensus Healthcare has scheduled its second-quarter 2026 financial results release for August 13, 2026. A conference call will be held on the same day at 4:30 p.m. ET to discuss the results, provide a business update, and answer questions. Webcast access will be available …

HA Sustainable Infrastructure Capital (HASI) to Release Earnings on Thursday

HA Sustainable Infrastructure Capital (HASI) is set to release its Q2 2026 earnings on Thursday, August 6th, with analysts forecasting $0.73 EPS and $111.95 million in revenue. The company previously exceeded expectations in Q1, reporting $0.77 EPS. HASI shares recently traded down 3% at …

Public Employees Retirement System of Ohio Has $4.27 Million Holdings in Consensus Cloud Solutions, Inc. $CCSI

The Public Employees Retirement System of Ohio increased its stake in Consensus Cloud Solutions, Inc. (NASDAQ:CCSI) by 27% in the first quarter, now holding 179,767 shares valued at $4.27 million. The company has a "Moderate Buy" consensus rating from analysts with an average price …

Consensus Cloud Solutions (CCSI) Expected to Release Earnings on Thursday

Consensus Cloud Solutions (CCSI) is anticipated to report its Q2 2026 earnings on Thursday, August 6th, with analysts projecting $1.49 EPS and $89.63 million in revenue. The company surpassed analyst expectations in the previous quarter with $1.52 EPS and $88.47 million in revenue. CCSI …

Tarsus Pharmaceuticals (TARS) Could Be 38% Undervalued Following Cautious Earnings Expectations

Tarsus Pharmaceuticals (TARS) is heading into its quarterly report with expectations of a loss but higher revenue. Despite a 27.6% year-to-date share price decline, the company is considered 37.8% undervalued with a fair value of $94.11, based on rapid revenue expansion, anticipated profitability shifts, …

Acusensus (ASX:ACE) Rises 5% on Road-Safety Tech Growth

Tarsus Pharmaceuticals (TARS) Projected to Release Earnings on Thursday

Tarsus Pharmaceuticals, Inc. (TARS) May Report Negative Earnings: Know the Trend Ahead of Q2 Release

Tarsus Pharmaceuticals, Inc. (TARS) is projected to report a year-over-year increase in earnings and higher revenues for Q2 2026, though a negative Earnings ESP and Zacks Rank #4 suggest it might not beat consensus EPS estimates. Analysts have become more bearish on the company's …